BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25713290)

  • 1. Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.
    Schisler JC; Grevengoed TJ; Pascual F; Cooper DE; Ellis JM; Paul DS; Willis MS; Patterson C; Jia W; Coleman RA
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Transition From Decompensated to Pathological Hypertrophy.
    Pascual F; Schisler JC; Grevengoed TJ; Willis MS; Coleman RA
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
    Paul DS; Grevengoed TJ; Pascual F; Ellis JM; Willis MS; Coleman RA
    Biochim Biophys Acta; 2014 Jun; 1841(6):880-7. PubMed ID: 24631848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
    Ellis JM; Mentock SM; Depetrillo MA; Koves TR; Sen S; Watkins SM; Muoio DM; Cline GW; Taegtmeyer H; Shulman GI; Willis MS; Coleman RA
    Mol Cell Biol; 2011 Mar; 31(6):1252-62. PubMed ID: 21245374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.
    Grevengoed TJ; Cooper DE; Young PA; Ellis JM; Coleman RA
    FASEB J; 2015 Nov; 29(11):4641-53. PubMed ID: 26220174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
    Zhao L; Pascual F; Bacudio L; Suchanek AL; Young PA; Li LO; Martin SA; Camporez JP; Perry RJ; Shulman GI; Klett EL; Coleman RA
    J Biol Chem; 2019 May; 294(22):8819-8833. PubMed ID: 30975900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
    Goldenberg JR; Wang X; Lewandowski ED
    J Mol Cell Cardiol; 2016 May; 94():1-9. PubMed ID: 26995156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.
    Durgan DJ; Smith JK; Hotze MA; Egbejimi O; Cuthbert KD; Zaha VG; Dyck JR; Abel ED; Young ME
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2480-97. PubMed ID: 16428347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis.
    Li LO; Grevengoed TJ; Paul DS; Ilkayeva O; Koves TR; Pascual F; Newgard CB; Muoio DM; Coleman RA
    Diabetes; 2015 Jan; 64(1):23-35. PubMed ID: 25071025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart.
    de Jong H; Neal AC; Coleman RA; Lewin TM
    Biochim Biophys Acta; 2007 Jan; 1771(1):75-82. PubMed ID: 17197235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function.
    Grevengoed TJ; Martin SA; Katunga L; Cooper DE; Anderson EJ; Murphy RC; Coleman RA
    J Lipid Res; 2015 Aug; 56(8):1572-82. PubMed ID: 26136511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α.
    Zhu Y; Soto J; Anderson B; Riehle C; Zhang YC; Wende AR; Jones D; McClain DA; Abel ED
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H41-51. PubMed ID: 23624629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift.
    Wang L; Ko KW; Lucchinetti E; Zhang L; Troxler H; Hersberger M; Omar MA; Posse de Chaves EI; Lopaschuk GD; Clanachan AS; Zaugg M
    Anesthesiology; 2010 Sep; 113(3):541-51. PubMed ID: 20683255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
    Li LO; Ellis JM; Paich HA; Wang S; Gong N; Altshuller G; Thresher RJ; Koves TR; Watkins SM; Muoio DM; Cline GW; Shulman GI; Coleman RA
    J Biol Chem; 2009 Oct; 284(41):27816-27826. PubMed ID: 19648649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
    Das A; Durrant D; Koka S; Salloum FN; Xi L; Kukreja RC
    J Biol Chem; 2014 Feb; 289(7):4145-60. PubMed ID: 24371138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice.
    de Brouwer KF; Degens H; Aartsen WM; Lindhout M; Bitsch NJ; Gilde AJ; Willemsen PH; Janssen BJ; van der Vusse GJ; van Bilsen M
    J Mol Cell Cardiol; 2006 Jun; 40(6):838-45. PubMed ID: 16697005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes.
    Li LO; Mashek DG; An J; Doughman SD; Newgard CB; Coleman RA
    J Biol Chem; 2006 Dec; 281(48):37246-55. PubMed ID: 17028193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.